JP2022521781A5 - - Google Patents

Info

Publication number
JP2022521781A5
JP2022521781A5 JP2021549902A JP2021549902A JP2022521781A5 JP 2022521781 A5 JP2022521781 A5 JP 2022521781A5 JP 2021549902 A JP2021549902 A JP 2021549902A JP 2021549902 A JP2021549902 A JP 2021549902A JP 2022521781 A5 JP2022521781 A5 JP 2022521781A5
Authority
JP
Japan
Prior art keywords
target
cancer
item
stranded
oligonucleotide domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021549902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521781A (ja
JP7344973B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020529 external-priority patent/WO2020180741A1/en
Publication of JP2022521781A publication Critical patent/JP2022521781A/ja
Publication of JP2022521781A5 publication Critical patent/JP2022521781A5/ja
Application granted granted Critical
Publication of JP7344973B2 publication Critical patent/JP7344973B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549902A 2019-03-01 2020-02-28 標的実体を検出するためのシステム、組成物、及び方法 Active JP7344973B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962812878P 2019-03-01 2019-03-01
US62/812,878 2019-03-01
US202062962722P 2020-01-17 2020-01-17
US62/962,722 2020-01-17
PCT/US2020/020529 WO2020180741A1 (en) 2019-03-01 2020-02-28 Systems, compositions, and methods for target entity detection

Publications (3)

Publication Number Publication Date
JP2022521781A JP2022521781A (ja) 2022-04-12
JP2022521781A5 true JP2022521781A5 (cg-RX-API-DMAC7.html) 2023-03-09
JP7344973B2 JP7344973B2 (ja) 2023-09-14

Family

ID=72338354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021549902A Active JP7344973B2 (ja) 2019-03-01 2020-02-28 標的実体を検出するためのシステム、組成物、及び方法

Country Status (9)

Country Link
US (3) US11085089B2 (cg-RX-API-DMAC7.html)
EP (2) EP3931351B1 (cg-RX-API-DMAC7.html)
JP (1) JP7344973B2 (cg-RX-API-DMAC7.html)
KR (1) KR102599718B1 (cg-RX-API-DMAC7.html)
CN (1) CN113748217B (cg-RX-API-DMAC7.html)
AU (2) AU2020233286B2 (cg-RX-API-DMAC7.html)
CA (1) CA3129868A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202109423TA (cg-RX-API-DMAC7.html)
WO (1) WO2020180741A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3129868A1 (en) 2019-03-01 2020-09-10 Mercy Bioanalytics, Inc. Systems, compositions, and methods for target entity detection
DE102020003794A1 (de) * 2020-06-25 2021-12-30 Forschungszentrum Jülich GmbH Verfahren, Verwendung des Verfahrens sowle Kit zum Nachweis von Bioindikatoren in einer Probe
EP4301782A1 (en) 2021-03-05 2024-01-10 Go Therapeutics, Inc. Anti-glyco-cd44 antibodies and their uses
JP7580154B2 (ja) * 2021-04-12 2024-11-11 国立研究開発法人物質・材料研究機構 共重合体、抗体-共重合体コンジュゲート作成キット、抗体-共重合体コンジュゲート、抗原の濃縮方法、及び、抗原の検出方法
US12704508B2 (en) 2021-06-02 2026-08-11 Alamar Biosciences, Inc. Nucleic acid linked immune-sandwich assay (NULISA)
CA3227131A1 (en) * 2021-07-21 2023-01-26 Mercy Bioanalytics, Inc. Compositions and methods for detection of prostate cancer
CA3227124A1 (en) * 2021-07-21 2023-01-26 Mercy Bioanalytics, Inc. Compositions and methods for detection of pancreatic cancer
US20240369558A1 (en) * 2021-07-21 2024-11-07 Mercy Bioanalytics, Inc. Compositions and methods for detection of breast cancer
WO2023004083A2 (en) * 2021-07-21 2023-01-26 Mercy Bioanalytics, Inc. Compositions and methods for detection of bile duct cancer
CA3227148A1 (en) * 2021-07-21 2023-01-26 Mercy Bioanalytics, Inc. Compositions and methods for detection of colorectal cancer
WO2023004087A2 (en) * 2021-07-21 2023-01-26 Mercy Bioanalytics, Inc. Compositions and methods for cancer detection
US20250297317A1 (en) * 2021-07-21 2025-09-25 Mercy Bioanalytics, Inc. Compositions and methods for detection of liver cancer
US20250043357A1 (en) * 2021-07-21 2025-02-06 Mercy Bioanalytics, Inc. Compositions and methods for detection of esophageal cancer
JP2024531915A (ja) 2021-08-05 2024-09-03 ジーオー セラピューティクス,インコーポレイテッド 抗グリコmuc抗体およびその使用
WO2023034569A1 (en) 2021-09-03 2023-03-09 Go Therapeutics, Inc. Anti-glyco-cmet antibodies and their uses
JP2024534910A (ja) 2021-09-03 2024-09-26 ジーオー セラピューティクス,インコーポレイテッド 抗グリコlamp1抗体およびその使用
EP4433827A4 (en) * 2021-11-17 2026-01-14 Mercy Bioanalytics Inc Compositions and Methods of Ovarian Cancer Detection
CN120584193A (zh) * 2022-11-23 2025-09-02 润知生物技术公司 用于蛋白质分析物的检测的组合物和方法
WO2025252658A1 (en) 2024-06-03 2025-12-11 Olink Proteomics Ab New product and method

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795714A (en) 1992-11-06 1998-08-18 Trustees Of Boston University Method for replicating an array of nucleic acid probes
CA2118759C (en) 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood
US20020025519A1 (en) * 1999-06-17 2002-02-28 David J. Wright Methods and oligonucleotides for detecting nucleic acid sequence variations
US7306904B2 (en) 2000-02-18 2007-12-11 Olink Ab Methods and kits for proximity probing
US8013134B2 (en) 2001-11-23 2011-09-06 Olink Ab Kit for proximity probing with multivalent proximity probes
TWI375796B (en) 2003-04-18 2012-11-01 Becton Dickinson Co Immuno-amplification
PT1633888E (pt) 2003-06-17 2009-04-22 Keygene Nv Meios e método para a detecção de sequências de nucleótidos alvo utilizando ensaios de ligação com pares de sondas de oligonucleótido melhoradas
WO2005123963A2 (en) 2004-06-14 2005-12-29 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for use in analyte detection using proximity probes
GB0605584D0 (en) 2006-03-20 2006-04-26 Olink Ab Method for analyte detection using proximity probes
US8758991B2 (en) 2006-04-26 2014-06-24 University Of Louisville Research Foundation, Inc. Isolation of membrane vesicles from biological fluids and methods of using same
CA2705486C (en) 2007-11-19 2019-04-02 Celera Corporation Lung cancer markers and uses thereof
US8481698B2 (en) 2009-03-19 2013-07-09 The President And Fellows Of Harvard College Parallel proximity ligation event analysis
GB201004292D0 (en) 2010-03-15 2010-04-28 Olink Ab Assay for localised detection of analytes
US10066257B2 (en) * 2010-03-29 2018-09-04 Dxterity Diagnostics Incorporated Methods and compositions for detecting target nucleic acids
WO2012049316A1 (en) 2010-10-15 2012-04-19 Olink Ab Dynamic range methods
CA2817111C (en) 2010-11-10 2019-03-05 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
GB201101621D0 (en) 2011-01-31 2011-03-16 Olink Ab Method and product
CA2835641C (en) 2011-05-11 2019-05-28 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
GB201108678D0 (en) 2011-05-24 2011-07-06 Olink Ab Multiplexed proximity ligation assay
EP2776587A4 (en) 2011-11-10 2015-07-15 Exosome Diagnostics Inc LIQUOR ASSAY
US9029086B2 (en) 2012-01-26 2015-05-12 Masood Kamali Moghaddam Detection of single and multimodal analytes
EP2875158A4 (en) 2012-07-18 2016-03-23 Exosome Diagnostics Inc USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN
US20150252428A1 (en) 2012-10-03 2015-09-10 Exosome Diagnostics, Inc. Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
US10174366B2 (en) 2012-11-14 2019-01-08 Olink Bioscience Ab Localised RCA-based amplification method
US20160369321A1 (en) 2012-11-14 2016-12-22 Olink Ab RCA Reporter Probes and Their Use in Detecting Nucleic Acid Molecules
US9086412B2 (en) 2012-12-31 2015-07-21 University Of Louisville Research Foundation, Inc. Extracellular vesicle-associated protein markers of cancer
BR112015016136A2 (pt) 2013-01-03 2017-07-11 Exosome Diagnostics Inc métodos para isolar microvesículas
CA2920429C (en) 2013-08-06 2021-11-16 Exosome Diagnostics, Inc. Urine biomarker cohorts, gene expression signatures, and methods of use thereof
BR112016004153A2 (pt) * 2013-08-28 2019-09-17 Caris Life Sciences Switzerland Holdings Gmbh "método para caracterizar uma doença ou distúrbio, kit, composição, método para gerar uma biblioteca de entrada, oligonucleotídeo, pluralidade de oligonucleotídeos e método para identificar um aptâmero
ES2875998T3 (es) 2013-09-30 2021-11-11 Vesicode Ab Procedimientos de perfilado de complejos moleculares mediante el uso de códigos de barras dependientes de la proximidad
GB201401885D0 (en) 2014-02-04 2014-03-19 Olink Ab Proximity assay with detection based on hybridisation chain reaction (HCR)
WO2015130956A2 (en) 2014-02-28 2015-09-03 Exosome Sciences, Inc. Brain specific exosome based diagnostics and extracorporeal therapies
KR102757668B1 (ko) 2014-05-15 2025-01-21 메소 스케일 테크놀러지즈, 엘엘시 개선된 분석 방법
ES2935285T3 (es) * 2014-06-06 2023-03-03 Univ Cornell Método para identificación y enumeración de cambios en la secuencia de ácidos nucleicos, expresión, copia, o metilación de ADN, usando reacciones combinadas de nucleasa, ligasa, polimerasa y secuenciación
WO2015193427A1 (en) 2014-06-19 2015-12-23 Olink Ab Determination and analysis of biomarkers in clinical samples
JP2017537657A (ja) 2014-12-11 2017-12-21 ニユー・イングランド・バイオレイブス・インコーポレイテツド 標的配列の濃縮
US11175286B2 (en) * 2015-01-09 2021-11-16 Spot Biosystems Ltd. Immunolipoplex nanoparticle biochip containing molecular probes for capture and characterization of extracellular vesicles
US20180066262A1 (en) * 2015-03-09 2018-03-08 Caris Science, Inc. Oligonucleotide probes and uses thereof
JP6921809B2 (ja) * 2015-09-22 2021-08-18 トラスティーズ オブ ボストン ユニバーシティ ナノ小胞の多重表現型決定法
GB201518655D0 (en) 2015-10-21 2015-12-02 Olink Ab Method for generating proximity probes
US10526665B2 (en) 2016-03-04 2020-01-07 University Of Notre Dame Du Lac Exosomal biomarkers diagnostic of tuberculosis
PT3464628T (pt) * 2016-06-06 2024-06-03 Redvault Biosciences Lp Construções repórter de alvo e suas utilizações
WO2018102162A1 (en) * 2016-11-30 2018-06-07 Exosome Diagnostics, Inc. Methods and compositions to detect mutations in plasma using exosomal rna and cell free dna from non-small cell lung cancer patients
WO2018119455A1 (en) 2016-12-23 2018-06-28 Exosome Diagnostics, Inc. Biofluid analysis and quantitation systems and methods
EP3652315A4 (en) * 2017-07-12 2021-09-01 Exosome Diagnostics, Inc. METHODS FOR ISOLATION AND ENRICHMENT OF EXTRACELLULAR VESICLE POPULATIONS DERIVED FROM BIOFLUIDS, AND ASSOCIATED METHODS OF USE
US11345957B2 (en) 2017-07-18 2022-05-31 Exosome Diagnostics, Inc. Methods of treating glioblastoma in a subject informed by exosomal RNA signatures
WO2019022542A2 (ko) 2017-07-26 2019-01-31 ㈜로제타엑소좀 양이온을 이용한 세포밖 소포체의 분리 방법
JP2020528766A (ja) 2017-07-26 2020-10-01 ロゼッタ エクソソーム 陽イオンを利用した細胞外小胞体の分離方法
WO2019066501A1 (ko) 2017-09-27 2019-04-04 ㈜로제타엑소좀 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 분석 방법 및 이의 용도
WO2019103548A2 (ko) 2017-11-24 2019-05-31 ㈜로제타엑소좀 반건식 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 분리 방법
US20200362334A1 (en) * 2017-12-07 2020-11-19 The Broad Institute, Inc. High-throughput methods for identifying gene interactions and networks
EP3793715A2 (en) * 2018-05-17 2021-03-24 Meso Scale Technologies, LLC Methods for isolating surface marker displaying agents
WO2019236853A1 (en) 2018-06-06 2019-12-12 Exosome Diagnostics, Inc. Methods for developing urine biomarkers and for detecting bladder cancer
WO2019238944A1 (en) 2018-06-15 2019-12-19 Olink Proteomics Ab Biomarker panel for ovarian cancer
US12631624B2 (en) * 2018-10-23 2026-05-19 Meso Scale Technologies, Llc. Methods for isolating surface marker displaying agents
EP3884045B1 (en) 2018-11-20 2023-01-11 Exosome Diagnostics, Inc. Methods for internal controls of microvesicle isolations
CA3129868A1 (en) 2019-03-01 2020-09-10 Mercy Bioanalytics, Inc. Systems, compositions, and methods for target entity detection
KR20220129591A (ko) * 2020-01-17 2022-09-23 메르시 바이오애널리틱스, 인코포레이티드 난소암의 검출을 위한 조성물 및 방법

Similar Documents

Publication Publication Date Title
JP7344973B2 (ja) 標的実体を検出するためのシステム、組成物、及び方法
JP6770957B2 (ja) 試料中のpik3ca突然変異状態を決定する方法
CN104620109B (zh) 膀胱癌检测组合物、试剂盒及相关的方法
Shoda et al. HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study
US20240011993A1 (en) Compositions and methods for detection of lung cancer
JP2023533970A5 (cg-RX-API-DMAC7.html)
JP2019520791A (ja) 5−ヒドロキシメチル化無細胞系dnaをシーケンシングすることによる非侵襲性診断
JP2016047044A (ja) Bcl−2ファミリー阻害剤耐性腫瘍及び癌を有する被験者を同定、分類及びモニターするための方法及び組成物
US20190285518A1 (en) Methods for personalized detection of the recurrence of cancer or metastasis and/or evaluation of treatment response
US20230243834A1 (en) Compositions and methods for detection of ovarian cancer
KR20110061572A (ko) Dna를 정량 또는 검출하는 방법
JP5430407B2 (ja) 遺伝子発現分析データの正規化のための参照遺伝子
JP2023510911A5 (cg-RX-API-DMAC7.html)
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
US20250223649A1 (en) Compositions and methods for detection of lung cancer
US12391985B2 (en) Method of determining PIK3CA mutational status in a sample
JP2012244989A (ja) リアルタイム重合反応を用いた癌診断のための情報提供方法及びこのための癌診断用キット
JP7843592B2 (ja) がんのスクリーニング、診断、治療、及び再発における巨細胞の核酸の特徴付けの使用方法
JP6608424B2 (ja) 前癌性結腸直腸ポリープおよび結腸直腸癌を特定するための方法およびキット
JP2017531424A (ja) ハイブリッド多元ステップ核酸増幅
CN105567862B (zh) Cdk18在制备诊断冠心病产品中的用途
US20260117306A1 (en) Use of multi-nucleotide and structural variants for improved sensitivity and specificity of circulating tumor dna assays
Wang et al. t (11; 18)(q21; q21) in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in stomach: a study of 48 cases
JP2023525760A (ja) 血漿および唾液のリキッドバイオプシープラットフォーム
WO2024137664A1 (en) Methods for detecting glioblastoma in extracellular vesicles